<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Binaytara Foundation on Medium]]></title>
        <description><![CDATA[Stories by Binaytara Foundation on Medium]]></description>
        <link>https://medium.com/@btfnews?source=rss-a062686399a1------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*6pEzSp0nbkGgC75BIrkWrw.png</url>
            <title>Stories by Binaytara Foundation on Medium</title>
            <link>https://medium.com/@btfnews?source=rss-a062686399a1------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 13:51:36 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@btfnews/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Faculty Highlight: Dr. Shailender Bhatia]]></title>
            <link>https://btfnews.medium.com/faculty-highlight-dr-shailender-bhatia-64021ed86162?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/64021ed86162</guid>
            <category><![CDATA[featured]]></category>
            <category><![CDATA[faculty]]></category>
            <category><![CDATA[cancerdisparity]]></category>
            <category><![CDATA[cancer-summit]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Wed, 26 Jul 2023 19:58:10 GMT</pubDate>
            <atom:updated>2023-07-26T19:58:10.783Z</atom:updated>
            <content:encoded><![CDATA[<p>We are excited to introduce Dr. Shailender Bhatia, our featured faculty member from SCHD 2023!</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FrulummJYj0A%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DrulummJYj0A&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FrulummJYj0A%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/1a7c11136d4ac37fcfed1affa28bb735/href">https://medium.com/media/1a7c11136d4ac37fcfed1affa28bb735/href</a></iframe><h3>Faculty Bio</h3><p>Dr. Shailender Bhatia is a medical oncologist who specializes in the care of patients with advanced skin cancers. He is the Director of the Melanoma and Renal Cancer Team at <a href="https://www.fredhutch.org/en.html">Fred Hutchinson Cancer Center</a> and a professor and physician at <a href="https://www.uwmedicine.org/">UW Medicine</a>.</p><p>He is committed to developing clinical trials that focus on improving outcomes for patients with skin cancers, especially melanoma, Merkel cell carcinoma, and other non-melanoma skin cancers. His research interests also include intra-tumoral immunotherapy, a form of treatment where cancer medications are injected directly into a tumor to improve treatment responses while reducing systemic toxicity.</p><p>Dr. Shailender Bhatia has been involved with the Binaytara Foundation for many years, leading conferences and sharing his knowledge. Most recently, he received the <a href="https://binayfoundation.org/btf-awards/">BTF Distinguished Faculty Award</a>, which recognizes individuals who have demonstrated long-standing excellence in teaching and improving access to education for health care providers.</p><h3>About Binaytara Foundation</h3><p>Founded in 2007, Binaytara Foundation (BTF) is an international non-profit organization dedicated to improving access to cancer care. Through educational and innovative approaches, BTF aims to eliminate socioeconomic barriers in the field of oncology and hematology.</p><p>Binaytara Foundation organizes a significant number of <a href="https://education.binayfoundation.org/">hematology and oncology conferences</a> on a regional, national, and international basis. Binaytara Foundation is most noted for constructing a 200-bed state-of-the-art cancer hospital in <a href="https://cancer.binayfoundation.org/">Janakpur, Nepal</a>. BTF also assisted in building the first bone marrow transplant center in Kathmandu, Nepal, and palliative care initiatives in South Asia.</p><p>Please visit the organization’s <a href="http://founded%20in%202007%2C%20binaytara%20foundation%20%28btf%29%20is%20a%20global%20non-profit%20organization%20dedicated%20to%20improving%20cancer%20care%20access%20through%20effective%20education%20and%20innovation%20models%2C%20aiming%20to%20break%20down%20socioeconomic%20barriers%20and%20advance%20the%20best%20practices%20in%20worldwide%20oncology%20and%20hematology.%20%20binaytara%20is%20one%20of%20the%20largest%20hematology%20and%20oncology%20continuing%20education%20providers%20in%20the%20united%20states%2C%20organizing%20a%20large%20number%20of%20regional%2C%20national%2C%20and%20global%20cme-accredited%20hematology%20and%20oncology%20conferences.%20the%20most%20notable%20project%20from%20the%20binaytara%20foundation%20is%20establishing%20a%20state-of-the-art%2C%20200-bed%20cancer%20hospital%20in%20janakpur%2C%20nepal.%20btf%20has%20also%20assisted%20in%20establishing%20palliative%20care%20programs%20in%20south%20asia%20and%20the%20first%20bone%20marrow%20transplant%20center%20in%20kathmandu%2C%20nepal.%20please%20visit%20the%20organization%27s%20website%20to%20learn%20more%20about%20binaytara%20foundation%27s%20impact%20missions./">website </a>to learn more about the Binaytara Foundation’s impact missions.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=64021ed86162" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Faculty Highlight: Dr. Narjust Florez]]></title>
            <link>https://btfnews.medium.com/faculty-highlight-dr-narjust-florez-1487dba7d438?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/1487dba7d438</guid>
            <category><![CDATA[cancer-summit]]></category>
            <category><![CDATA[cancerdisparity]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Wed, 26 Jul 2023 19:56:32 GMT</pubDate>
            <atom:updated>2023-07-26T19:56:32.088Z</atom:updated>
            <content:encoded><![CDATA[<p>Dr. Florez participated in the 2023 Summit on Cancer Health Disparities (SCHD). She was a panelist in the Career in Oncology — Success Lounge, sharing about disparities surrounding women in the field. Watch the video to learn about why SCHD is unique in how it addresses cancer health disparities.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FUMarKmd1dZ4%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DUMarKmd1dZ4&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FUMarKmd1dZ4%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/df2a78d12392d2626118f523ac554d7a/href">https://medium.com/media/df2a78d12392d2626118f523ac554d7a/href</a></iframe><h3>Faculty Bio</h3><p>Dr. Narjust Florez is originally from Venezuela. She completed her internal medicine residency at Rutgers New Jersey Medical School and fellowship at the Mayo Clinic in Rochester, Minnesota, where she was the chief fellow from 2018–2019.</p><p>She is the Associate Director of the Cancer Care Equity Program, a thoracic medical oncologist at the <a href="https://www.dana-farber.org/">Dana-Farber Cancer Institute/Harvard Cancer Center</a>, and an Assistant Professor of Medicine at Harvard Medical School. In 2022, Dr. Florez also became the first Latina to hold an Associate Editor position in oncology as the new Associate Editor for Diversity, Equity and Inclusion at the JAMA Oncology Journal.</p><p>Dr. Narjust Florez’s clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.</p><h3>About Binaytara Foundation</h3><p>Founded in 2007, the Binaytara Foundation (BTF) is an international non-profit organization dedicated to improving access to cancer care. Through educational and innovative approaches, BTF aims to eliminate socioeconomic barriers in the field of oncology and hematology.</p><p>The Binaytara Foundation organizes a significant number of <a href="https://education.binayfoundation.org/">hematology and oncology conferences</a> on a regional, national, and international basis. The Binaytara Foundation is most noted for constructing a 200-bed state-of-the-art cancer hospital in <a href="https://cancer.binayfoundation.org/">Janakpur, Nepal</a>. BTF also assisted in building the first bone marrow transplant center in Kathmandu, Nepal, and palliative care initiatives in South Asia.</p><p>Please visit the organization’s <a href="http://founded%20in%202007%2C%20binaytara%20foundation%20%28btf%29%20is%20a%20global%20non-profit%20organization%20dedicated%20to%20improving%20cancer%20care%20access%20through%20effective%20education%20and%20innovation%20models%2C%20aiming%20to%20break%20down%20socioeconomic%20barriers%20and%20advance%20the%20best%20practices%20in%20worldwide%20oncology%20and%20hematology.%20%20binaytara%20is%20one%20of%20the%20largest%20hematology%20and%20oncology%20continuing%20education%20providers%20in%20the%20united%20states%2C%20organizing%20a%20large%20number%20of%20regional%2C%20national%2C%20and%20global%20cme-accredited%20hematology%20and%20oncology%20conferences.%20the%20most%20notable%20project%20from%20the%20binaytara%20foundation%20is%20establishing%20a%20state-of-the-art%2C%20200-bed%20cancer%20hospital%20in%20janakpur%2C%20nepal.%20btf%20has%20also%20assisted%20in%20establishing%20palliative%20care%20programs%20in%20south%20asia%20and%20the%20first%20bone%20marrow%20transplant%20center%20in%20kathmandu%2C%20nepal.%20please%20visit%20the%20organization%27s%20website%20to%20learn%20more%20about%20binaytara%20foundation%27s%20impact%20missions./">website </a>to learn more about the Binaytara Foundation’s impact mission.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1487dba7d438" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Conference Co-Chair Spotlight — Best of ASCO Boise 2023]]></title>
            <link>https://btfnews.medium.com/conference-co-chair-spotlight-best-of-asco-boise-2023-6ab060f24022?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/6ab060f24022</guid>
            <category><![CDATA[conference-chairs]]></category>
            <category><![CDATA[oncology]]></category>
            <category><![CDATA[asco]]></category>
            <category><![CDATA[spotlight]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Tue, 25 Jul 2023 22:04:02 GMT</pubDate>
            <atom:updated>2023-07-25T22:04:02.203Z</atom:updated>
            <content:encoded><![CDATA[<h3>Conference Co-Chair Spotlight — Best of ASCO Boise 2023</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*__SMgZa16m_dsT4fa_xZCg.png" /></figure><h3>Dr. Mark Lewis and Dr. Christos Vaklavas co-chair BTF’s officially licensed Best of ASCO Boise, ID</h3><p>Drs. Christos Vaklavas of Huntsman Cancer Institute and Mark Lewis of Intermountain Health co-chaired the Binaytara Foundation’s 2023 Best of ASCO conference in Boise, ID, on July 15th and 16th, 2023. As the conference co-chairs, Dr. Vaklavas &amp; Dr. Lewis played a crucial role in the planning and implementation of this important oncology conference designed to educate local and regional oncology care providers about the updates from the <a href="https://asco.org/">American Society of Clinical Oncology</a> Annual Meeting held in Chicago earlier in June 2023.</p><p>As the leader in oncology continuing education, Binaytara Foundation (BTF) organizes local, regional, and national oncology conferences throughout the United States. In 2023, BTF is hosting three officially licensed Best of ASCO conferences, including one in Portland, OR on June 24–25, 2023; another in Boise, ID, on July 15–16, 2023; and the third one in Minneapolis, MN, on August 12–13, 2023.</p><p>As an organization dedicated to minimizing cancer health disparities through education, advocacy, and innovation, BTF is committed to bringing high-quality continuing education to cancer care practitioners wherever they live. We want to thank Drs. Vaklavas and Lewis for their role in helping us achieve this goal.</p><p>BTF assistant communication coordinator Taylor Sageman sat down with Drs. Lewis and Vaklavas for brief interviews to share their experiences planning and implementing the Best of ASCO Boise.</p><h3>Dr. Christos Vaklavas</h3><p>Dr. Vaklavas is a breast oncologist and an associate professor of medical oncology at the University of Utah, <a href="https://healthcare.utah.edu/huntsmancancerinstitute/">Huntsman Cancer Institute</a>. His research focuses on translational and new compound discoveries for breast cancer treatment. He serves as the principal investigator for many breast cancer clinical trials at Huntsman.</p><p>Watch the <a href="https://youtu.be/-RuG6Ed94tw">video </a>to learn about Dr. Christos Vaklavas’ experience organizing this meeting in Boise!</p><h3>Dr. Mark Lewis</h3><p>As the Director of Gastrointestinal Oncology at <a href="https://intermountainhealthcare.org/">Intermountain Healthcare</a> in Salt Lake City, Utah, Dr. Mark Lewis specializes in cancers of the GI tract and accessory organs. His other areas of research interest include neuroendocrine and hereditary tumors.</p><p>In the interview, Dr. Lewis stressed the importance of ‘thinking globally, acting locally.’ As a self-diagnosed multiple endocrine neoplasia patient with the benefit of physician resources, he highlighted the importance of empathy towards communities with limited resources and referrals.</p><p>Dr. Mark Lewis also addressed his long-standing relationship with Binaytara Foundation and recounted his experience at the conference. This was his first conference co-chair role, but he has also attended several other BTF meetings.</p><p>Watch the <a href="https://youtu.be/WTu7SsSnU3M">video</a> to learn more about Dr. Mark Lewis and his experience as the Best of ASCO Boise conference co-chair!</p><h4>About Binaytara Foundation</h4><p>Binaytara Foundation (BTF) is an international global oncology non-profit organization dedicated to improving access to cancer care. Through education, advocacy, and innovations, BTF aims to improve access to cancer care for everyone around the world so that there are minimal to no disparities in cancer health outcomes.</p><h4>Minimizing Cancer Disparities Through Education and Innovation</h4><p>Binaytara Foundation is a leader in hematology and oncology continuing education. BTF’s multi-channel approach to oncology continuing education includes oncology conferences, <a href="https://cancernewsglobal.com/">The Cancer News</a>, The <a href="https://journal.binayfoundation.org/">International Journal of Cancer Care &amp; Delivery</a>, and virtual enduring materials.</p><h4>A Global Oncology Leader</h4><p>Binaytara Foundation’s global oncology programs include the establishment of a cancer hospital in Janakpurdham, Nepal. BTF’s prior global oncology programs include supporting the development of the first bone marrow transplant center in Kathmandu, Nepal, and palliative care initiatives in South Asia.</p><p>Please visit the organization’s <a href="https://binayfoundation.org/">website </a>to learn more about the Binaytara Foundation’s impact missions.</p><h4>BTF’s Officially Licensed Annual ASCO update Conferences</h4><p>Binaytara Foundation has hosted annual updates from the ASCO meeting in the pacific northwest since 2013, including licensed ASCO Direct Highlights and Best of ASCO meetings. BTF organized several other updates on hematology-oncology this year, including those in Alaska, California, Utah, Idaho, and Texas.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6ab060f24022" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Faculty Highlight — SCHD 2023]]></title>
            <link>https://btfnews.medium.com/faculty-highlight-schd-2023-839b5bd91af0?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/839b5bd91af0</guid>
            <category><![CDATA[faculty-highlight]]></category>
            <category><![CDATA[binaytara-foundation]]></category>
            <category><![CDATA[oncology-specialists]]></category>
            <category><![CDATA[schd-2023]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Mon, 10 Jul 2023 16:39:13 GMT</pubDate>
            <atom:updated>2023-07-10T16:39:13.747Z</atom:updated>
            <content:encoded><![CDATA[<h3>Faculty Highlight — SCHD 2023</h3><h3><strong>We are excited to introduce Dr. Jerald Radich, our featured faculty member at SCHD 2023!</strong></h3><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FNaOO5qcGfBY%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DNaOO5qcGfBY&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FNaOO5qcGfBY%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/2ce09d19712658ee9425664afc0be017/href">https://medium.com/media/2ce09d19712658ee9425664afc0be017/href</a></iframe><h3>Faculty Bio</h3><p>Dr. Jerald Radich is a medical oncologist specializing in the molecular genetics of leukemia. He studies genes and other molecules that signal treatment response, progression, and relapse.</p><p>Dr. Radich specializes in developing methods for improving the detection and treatment of chronic and acute myeloid leukemias (CMLs and AMLs). His team investigates how specific genetic variants influence treatment responses and outcomes. By analyzing these variants, Doctors could select the most effective treatment for their patients.</p><p>In addition, Dr. Radich directs <a href="https://www.fredhutch.org/en/faculty-lab-directory/radich-jerald.html">Fred Hutch’s Molecular Oncology Lab</a>, which provides high-quality molecular testing for clinical cancer researchers.</p><p>Click here to<a href="https://missionbio.com/company/sab/jerald-radich-md/"> learn more </a>about Dr. Jerald Radich.</p><h3>SCHD 2023</h3><p>The <a href="https://education.binayfoundation.org/2023-summit-cancer-health-disparities">Summit on Healthcare Disparities</a>, or SCHD 2023, promotes collaboration and partnerships across disciplines. Partnerships such as these generate new research and treatment paradigms, reduce cancer disparities, and improve patient outcomes.</p><p>Watch the video to learn more about Dr. Radich’s experience at SCHD 2023!</p><h3>About Binaytara Foundation</h3><p>Founded in 2007, Binaytara Foundation (BTF) is an international non-profit organization dedicated to improving access to cancer care. Through educational and innovative approaches, BTF aims to eliminate socioeconomic barriers in the field of oncology and hematology.</p><p>Binaytara Foundation organizes a significant number of hematology and oncology conferences on a regional, national, and international basis. Binaytara Foundation is most noted for constructing a 200-bed state-of-the-art cancer hospital in <a href="https://cancer.binayfoundation.org/">Janakpur, Nepal</a>. BTF also assisted in building the first bone marrow transplant center in Kathmandu, Nepal, and palliative care initiatives in South Asia.</p><p>Please visit the organization’s <a href="http://Founded in 2007, Binaytara Foundation (BTF) is a global non-profit organization dedicated to improving cancer care access through effective education and innovation models, aiming to break down socioeconomic barriers and advance the best practices in worldwide oncology and hematology.  Binaytara is one of the largest hematology and oncology continuing education providers in the United States, organizing a large number of regional, national, and global CME-accredited hematology and oncology conferences. The most notable project from the Binaytara Foundation is establishing a state-of-the-art, 200-bed cancer hospital in Janakpur, Nepal. BTF has also assisted in establishing palliative care programs in South Asia and the first bone marrow transplant center in Kathmandu, Nepal. Please visit the organization&#39;s website to learn more about Binaytara Foundation&#39;s impact missions.">website </a>to learn more about the Binaytara Foundation’s impact missions.</p><h3>support@binayfoundation.org</h3><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=839b5bd91af0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Binaytara Foundation Moves to New Office Space Amid Continued Growth]]></title>
            <link>https://btfnews.medium.com/binaytara-foundation-moves-to-new-office-space-amid-continued-growth-b208bec0ae94?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/b208bec0ae94</guid>
            <category><![CDATA[nonprofit]]></category>
            <category><![CDATA[new-office]]></category>
            <category><![CDATA[binaytara-foundation]]></category>
            <category><![CDATA[new-office-space]]></category>
            <category><![CDATA[office-relocation]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Mon, 03 Jul 2023 18:54:21 GMT</pubDate>
            <atom:updated>2023-07-03T18:54:21.608Z</atom:updated>
            <content:encoded><![CDATA[<h3>Relocation positions Binaytara Foundation for further development and organizational growth.</h3><p>Bellevue, WA, June 30, 2023 — Last week, Binaytara Foundation relocated from Issaquah, WA, to a new office space in Bellevue, WA. The primary purpose of this relocation was to accommodate the expanding team at the Binaytara Foundation.</p><p>Binaytara Foundation needed a new facility to help them organize and carry out tasks more efficiently as they grow. BTF’s previous office was considerably small and unsuitable for the growing non-profit. This recent expansion involves the consistent additions of faculty and staff, Binaytara’s expanding efforts in the U.S. Continuing Medical Education (CME) program, and their work towards internationally accessible cancer care in countries like Nepal.</p><p>Relocating to an advanced facility was essential to making even more effective strides in Binaytara Foundation’s mission to minimize cancer disparities on a global scale. BTF is in the early stages of developing ‘OncoBlast,’ a game-based app that will educate healthcare providers on clinical oncology and allow them to receive CME credit. Therefore, this new office space will be beneficial to that process.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/781/0*fEm3P-BTaTLo3WxC.jpg" /></figure><p>Dr. Binay Shah, co-founder and president of Binaytara Foundation, says moving offices was “necessary for the organization’s growth.” Similarly, Executive Director Tara Shah agreed with her co-founder and stated, “A larger space was needed for everybody to work well together.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*hm7cI59F4C2NSpMx.jpg" /></figure><h4>The new office can be found at <a href="https://www.cascadeyard.com/">Cascade Yard</a> in the Eastgate District of Bellevue, WA.</h4><p>Moving to a new office has already made a difference to the staff at BTF, even in the first week of adjustments. Since the non-profit organization went from working in a shared office space to a private one, the staff meetings are more productive and focused. The new office supports Binaytara’s team by offering necessary facilities for the growing organization.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*jqvHYVyOAZKVfSmi.jpg" /></figure><p>Overall, this is an exceptional milestone for Binaytara Foundation. It creates a great reflection of how much the company has grown, as they have continued to advocate, educate, and innovate to minimize disparities in global cancer care. Considering the multiple benefits of relocating, we can infer that this move is for the best of BTF.</p><p>Founded in 2007, Binaytara Foundation (BTF) is a global non-profit organization dedicated to improving cancer care access through effective education and innovation models, aiming to break down socioeconomic barriers and advance the best practices in worldwide oncology and hematology.</p><p>Binaytara is one of the largest hematology and oncology continuing education providers in the United States, organizing a large number of regional, national, and global CME-accredited <a href="https://education.binayfoundation.org/">hematology and oncology conferences</a>. The most notable project from the Binaytara Foundation is establishing a state-of-the-art, 200-bed cancer hospital in <a href="https://cancer.binayfoundation.org/">Janakpur, Nepal</a>. BTF has also assisted in establishing palliative care programs in South Asia and the first bone marrow transplant center in Kathmandu, Nepal. Please visit the organization’s <a href="https://binayfoundation.org/">website</a> to learn more about Binaytara Foundation’s impact missions.</p><p>For those interested in accelerating Binaytara Foundation’s efforts, donate <a href="https://binayfoundation.org/donate/">here</a> to change lives!</p><p>Binaytara Foundation</p><p>(425) 557–5953</p><p>support@binayfoundation.org</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b208bec0ae94" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Opportunity for Fellows and Early Career Oncologists to Receive BTF Career Advancement Awards]]></title>
            <link>https://btfnews.medium.com/opportunity-for-fellows-and-early-career-oncologists-to-receive-btf-career-advancement-awards-9ab0780eba56?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/9ab0780eba56</guid>
            <category><![CDATA[cancer-research]]></category>
            <category><![CDATA[awards]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Wed, 21 Jun 2023 18:39:03 GMT</pubDate>
            <atom:updated>2023-06-21T18:39:03.628Z</atom:updated>
            <content:encoded><![CDATA[<h3>Submit Your Abstract to the 2023 Summit on Hematologic Cancers &amp; Precision Oncology Summit for Consideration</h3><p>Bellevue, WA — The Binaytara Foundation announces an opportunity for fellows and early career oncologists and hematologists to receive the BTF Career Advancement Award at two upcoming conferences: <a href="https://education.binayfoundation.org/2023-annual-summit-hematologic-cancers#group-tabs-node-course-default7">the 2023 Annual Summit on Hematologic Cancers</a> on September 15–17, 2023 in Nashville, TN; and <a href="https://education.binayfoundation.org/content/2023-precision-oncology-summit-personalizing-treatment-improve-patient-outcomes#group-tabs-node-course-default7">the 2023 Precision Oncology Summit</a> on October 8–9, 2023 in San Francisco, CA. The top 50 highest-scoring abstracts submitted by residents, fellows, or early career faculty will receive complimentary registration, two free hotel nights during the conference, and $500.</p><h3>2023 Precision Oncology Summit</h3><p>ed by Dr. Alan Ashworth (President, <a href="https://cancer.ucsf.edu/">UCSF Cancer Center</a>), Dr. Mark Pegram (Medical Director, <a href="https://med.stanford.edu/ctru.html">Stanford Clinical Translational Research Unit</a>), and Dr. Pamela Munster (Professor of Medicine, <a href="https://www.ucsf.edu/">University of California, San Francisco</a>), the 2023 Precision Oncology Summit on October 7–8, 2023 in San Francisco, CA, features some of the most well-known experts in the field of precision oncology. Scientific sessions will include oral and poster abstract presentations. 25 Career Advancement Awards will be given to the top abstract submissions.</p><p>Check out what Dr. Jonathan Riess, of the <a href="https://www.ucdavis.edu/">University of California, Davis</a>, has to say!</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FJ1KeOld92rw%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DJ1KeOld92rw&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2FJ1KeOld92rw%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/8de5150768d10ff8aa6a33e0f6234dd4/href">https://medium.com/media/8de5150768d10ff8aa6a33e0f6234dd4/href</a></iframe><h3>2023 Annual Summit on Hematologic Cancers</h3><p>This inaugural conference features over 50 faculty members from leading academic centers in the United States. Conference chairs include Dr. Shaji Kumar (Professor of Medicine, <a href="https://www.mayoclinic.org/">Mayo Clinic</a>), Dr. Sonali Smith (Professor of Medicine, <a href="https://www.uchicago.edu/en">University of Chicago</a>), Dr. Navneet Majhail (Physician-in-Chief of Blood Cancers, <a href="https://sarahcannon.com/">Sarah Cannon</a>), and Dr. Nitin Jain (Associate Professor, <a href="https://www.mdanderson.org/">University of Texas MD Anderson Cancer Center</a>). 25 Career Advancement Awards will be given to the top abstract submissions.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*BrxRVpyIjIzxTjMGRfa0yg.jpeg" /></figure><h3>Submission Guidelines</h3><p>We will accept abstracts in the following categories. Please select a category that fits the submission best:<br>• Basic science research<br>• Clinical research<br>• Quality-of-care research<br>• Outcomes research<br>• Case reports and case-series</p><p>Residents, fellows, or early career faculty (within five years of completing fellowship) must be the abstract’s first author and must present at the conference.</p><p>Click <a href="https://education.binayfoundation.org/abstracts-2023">here</a> to submit your abstract!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*rLxqFga7i6r-5p2r2mckkw.jpeg" /></figure><h3>About the Binaytara Foundation</h3><p><a href="https://binayfoundation.org/">The Binaytara Foundation</a> (BTF) is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation organizes more than 30 <a href="https://binayfoundation.org/conference/">hematology and oncology conferences</a> in the United States. BTF’s current global oncology project includes establishing a 200-bed <a href="https://binayfoundation.org/cancer-hospital/">cancer hospital in Janakpur, Nepal</a>. BTF has supported the establishment of the only bone marrow transplant center (at <a href="https://csh.gov.np/en">Civil Service Hospital, Kathmandu</a>) in Nepal and hospice and palliative care programs in South Asia.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9ab0780eba56" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Binaytara Foundation Announces 2023 Award Winners]]></title>
            <link>https://btfnews.medium.com/binaytara-foundation-announces-2023-award-winners-8621822c06fb?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/8621822c06fb</guid>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[non-profit-organization]]></category>
            <category><![CDATA[awards]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Fri, 14 Apr 2023 20:42:30 GMT</pubDate>
            <atom:updated>2023-04-14T20:46:25.921Z</atom:updated>
            <content:encoded><![CDATA[<h3>Honoring Leaders in Health Equity, <br>Education, Humanitarianism, and Volunteerism</h3><p>Seattle, WA — The Binaytara Foundation, a non-profit organization committed to improving healthcare worldwide, has announced the winners of its 2023 awards. The awards recognize outstanding contributions to health equity, education, humanitarianism, and volunteerism.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MeESojlthk4pQMLV05Z46g.jpeg" /></figure><h3>2023 Lifetime Achievement Award</h3><p>The Binaytara Foundation will bestow the 2023 Lifetime Achievement Award on Dr. Edith P. Mitchell for her exceptional leadership and contributions to promoting health equity and improving the landscape of cancer health disparities. Dr. Mitchell established the Center to Eliminate Cancer Disparities at <a href="https://www.jeffersonhealth.org/clinical-specialties/cancer">Sidney Kimmel Cancer Center</a> in 2012 and has dedicated much of her career to cancer research and health equity.</p><p>She joined the Binaytara Foundation’s efforts to minimize cancer disparities in 2018 as a <a href="https://www.youtube.com/watch?v=TjMFl1xkO-A">faculty</a> at our inaugural Summit on Cancer Health Disparities in Seattle, including co-chairing the meeting in 2022. BTF President Dr. Binay Shah says, “Dr. Mitchell is an inspiration to many of us. We are grateful for the opportunity to learn from her and to work together in this mission to eliminate cancer disparities.”</p><h3>2023 Distinguished Faculty Awards</h3><p>The BTF’s Distinguished Faculty Award recognizes individuals who have demonstrated long-standing excellence in teaching and improving access to education for healthcare providers. This year’s Distinguished Faculty Awards go to Dr. Fengting Yan and Dr. Shailender Bhatia. Dr. Yan is a breast oncologist at the <a href="https://www.swedish.org/services/cancer-institute">Swedish Cancer Institute</a>, and Dr. Bhatia is the Director of the Melanoma and Renal Cancer Team at <a href="https://www.fredhutch.org/en.html">Fred Hutchinson Cancer Center</a> and a Professor at the University of Washington. Dr. Bhatia has contributed to our education mission since 2015, including <a href="https://www.youtube.com/watch?v=-MwUVJjFJZ0">chairing our annual ASCO review meetings</a>. Dr. Yan leads the Breast Cancer subcommittee of our <a href="https://education.binayfoundation.org/content/education-academy">Education Committee</a> and chairs our annual Highlights of SABCS and Women’s Cancer conference.</p><h3>2023 Rising Star in Health Equity Award</h3><p>The Rising Star in Health Equity Award recognizes individuals who demonstrate exceptional leadership in improving cancer in underprivileged communities. The 2023 Rising Star in Health Equity will be awarded to Dr. Subodh Mallik. Dr. Mallik is an internist at <a href="https://www.wardmemorial.com/">Ward Memorial <br> Hospital</a> in Texas, and his research focuses on reducing health disparities in cancer care. He has made an impact on the field, publishing numerous articles on health equity and serving on national committees focused on diversity and inclusion in healthcare. Dr. Mallik volunteers as the Chief Technology Officer for the <a href="https://cancer.binayfoundation.org/">Binaytara Foundation Cancer Center</a> in Nepal and oversees the Electronic Health Records implementation, updates, and compliance.</p><h3>2023 Humanitarian Award</h3><p>The Binaytara Foundation Humanitarian Award recognizes individuals who demonstrate the highest values of volunteerism, community engagement, dedication to improving access to cancer care, and collaboration with the Binaytara Foundation. This year’s award will be presented to Dr. Timothy Erickson, who has been <a href="https://www.youtube.com/watch?v=nrlG0XS--ZA&amp;t=201s">involved with the Foundation</a> since 2008 and became a board member in 2015. Dr. Erickson is an emergency medicine doctor at <a href="https://www.brighamandwomens.org/">Brigham and Women’s Hospital</a>. He has dedicated his career to improving healthcare in underserved communities around the world, including disaster response efforts in Haiti, Nepal, and Puerto Rico.</p><h3>2023 Volunteer of the Year</h3><p>Ms. Diane Aboulafia will receive the 2023 Volunteer of the Year Award. The Volunteer of the Year Award recognizes individuals who demonstrate unselfish and dedicated service to advancing the mission of the Binaytara Foundation to improve access to cancer care through exceptional leadership and volunteerism. Ms. Aboulafia has been a dedicated volunteer with the Binaytara Foundation for several years, contributing her time and expertise to a wide range of projects. She has helped organize fundraising events, provided administrative support, and served as a mentor to students interested in healthcare careers. Her commitment to the Foundation’s mission has been truly invaluable.</p><p>“We are thrilled to honor these outstanding individuals for their exceptional contributions to healthcare,” said Dr. Binay Shah, President of the Binaytara Foundation. “Their work is an inspiration to all of us, and we are grateful for their dedication and service.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*mywJ-Atf1fIdBkB4NqZfFA.jpeg" /></figure><p>These awards will be presented at the <a href="https://gala.binayfoundation.org/">Binaytara Foundation’s Annual Gala</a>, to be held on April 29, 2023, from 6:00–9:00 PM, at the Grand Hyatt in Seattle, Washington.</p><h3>About the Binaytara Foundation</h3><p>The <a href="https://binayfoundation.org/">Binaytara Foundation</a> is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. The Binaytara Foundation’s major projects include <a href="https://education.binayfoundation.org/">hematology and oncology conferences</a> and the establishment of a <a href="https://cancer.binayfoundation.org/">cancer hospital in Nepal</a>. <a href="https://binayfoundation.org/btfcc-patient-assistant-fund/">Donate here</a>!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8621822c06fb" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[US Physicians and Supporters Visit Binaytara Foundation Cancer Hospital in Nepal]]></title>
            <link>https://btfnews.medium.com/us-physicians-and-supporters-visit-binaytara-foundation-cancer-hospital-in-nepal-c999c4977bc2?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/c999c4977bc2</guid>
            <category><![CDATA[nepal]]></category>
            <category><![CDATA[cancer-treatments]]></category>
            <category><![CDATA[cancer]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Mon, 03 Apr 2023 22:36:21 GMT</pubDate>
            <atom:updated>2023-04-03T22:36:21.451Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*XEi1T-KcLpYnzFdz4BElRg.jpeg" /></figure><p>A group of the Binaytara Foundation’s supporters, led by BTF President Dr. Binay Shah, visited Nepal in March 2023. Traveling along with him were Dr. Mark Pegram of <a href="https://www.stanford.edu/">Stanford University</a>, Dr. Nora Ku, Vice President of Clinical Development at <a href="https://www.rainoncology.com/">Rain Oncology</a>, Dr. Wendy Wang of <a href="https://www.everettclinic.com/">Everett Clinic</a>, Ashley Farber of <a href="https://www.carislifesciences.com/">Caris Life Sciences</a>, and Nick Holik. The team visited Kathmandu and Janakpur, participated in health camps organized by the <a href="https://cancer.binayfoundation.org/">Binaytara Foundation Cancer Center</a>, and attended the International Cancer Congress meeting.</p><p>The two-day health camp offered cancer screening in Lohana, Janakpurdham, where the new 200-bed cancer hospital will be built. 328 patients were screened, allowing them to receive early detection and treatment.</p><p>When asked about the trip, Ashley Farber said, “We had the opportunity to immerse ourselves in the rich and vibrant Nepalese culture, lifestyle, and cuisine. Meeting the amazing people running the BTFCC, helping at the outpatient health clinic, and witnessing the oncology community coming together from around the world to share new and exciting research with their peers at the cancer conference brought joy into our hearts.”</p><p>The trip gave everyone a holistic understanding of the culture, history, and people that informed their view of our work at the BTFCC and our vision for improving cancer care in Nepal.</p><p>“The impact of the cancer center is immeasurable. Their vision of a state-of-the-art cancer care facility for the local people is inspiring. After visiting Janakpur and getting to know the locals’ culture, religion, and everyday life, I understand that the people there are more related to us and to the project BTF is pursuing. Knowing some of the highly treatable and curable cancers can be taken care of locally, I believe the new cancer hospital will change so many people’s lives.” Explained Dr. Wendy Wang.</p><p>“The most fulfilling portion of our visit was seeing the hospital, attending the teaching conference, visiting the outpatient health clinic, and attending the 5th annual International Cancer Conference. The BTFCC fills an unmet need, and the new hospital will further provide much-deserved services to the people of this community and region of Nepal.” Dr. Nora Ku said. “A fundamental change in the perception of healthcare access and delivery is the path defined by BTFCC. We hope our visit demonstrated to our medical colleagues in Nepal our support of the educational and healthcare mission of BTFCC and our respect for their efforts to deliver high-quality medical care to their patients.”</p><p>Ashley Farber expressed her support of our work, stating, “The Binaytara Foundation Cancer Center is a shining example of when the world comes together, we can help each other fight cancer. We are proud to be on this mission with the Binaytara Foundation to educate the world and save one life at a time.”</p><p>Support our mission and efforts to bring cancer care to the thousands of patients needing treatment, and <a href="https://binayfoundation.org/donate-now/">donate today</a>!</p><p>The <a href="https://binayfoundation.org/">Binaytara Foundation</a> is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a <a href="https://cancer.binayfoundation.org/">cancer hospital in Nepal</a>. Donate <a href="https://binayfoundation.org/donate-now/">here</a> to change lives!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c999c4977bc2" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Dr. Rubina Suwal of the Binaytara Foundation Cancer Center Receives ASCO Grant]]></title>
            <link>https://btfnews.medium.com/dr-rubina-suwal-of-the-binaytara-foundation-cancer-center-receives-asco-grant-4daef41dc4b7?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/4daef41dc4b7</guid>
            <category><![CDATA[press-release]]></category>
            <category><![CDATA[asco-grant]]></category>
            <category><![CDATA[cancer-center]]></category>
            <category><![CDATA[global-oncology]]></category>
            <category><![CDATA[oncology]]></category>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Fri, 24 Mar 2023 15:47:25 GMT</pubDate>
            <atom:updated>2023-03-24T15:47:25.020Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Grant will Fund Research on Effectiveness of Community Screening Program for Early Detection of Oral Cancers in Nepal</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*dh5FNEaH_rrewkcRIvp6ng.png" /></figure><p>The Binaytara Foundation and the Binaytara Foundation Cancer Center are proud to announce that Dr. Rubina Suwal, our head and neck surgical oncologist, has been awarded the 2023 Conquer Cancer International Innovation Grant from the American Society of Clinical Oncology (ASCO). Dr. Suwal’s research project titled “Effectiveness of a community screening program for early detection of oral cancers in Nepal” will be conducted over the next two years in Nepal.</p><p>Dr. Suwal’s research focuses on addressing the high incidence and mortality rates of oral cancers in Nepal. Early detection of oral cancer is crucial in improving survival rates, and Dr. Suwal’s study aims to evaluate the effectiveness of a community-based screening program in detecting oral cancers at an early stage in Nepal. The program will involve training community health workers to conduct oral cancer screenings and refer patients for further diagnosis and treatment.</p><p>“This grant will allow us to evaluate the effectiveness of a community-based oral cancer screening program in Nepal, which has the potential to significantly improve outcomes for patients,” said Dr. Suwal. “Our ultimate goal is to develop a sustainable model for early detection and treatment of oral cancers in Nepal that can be replicated in other low-resource settings.”</p><p>The Conquer Cancer International Innovation Grant is awarded to researchers who propose innovative approaches to improving cancer care in low and middle-income countries. The grant is supported by the Conquer Cancer Foundation of ASCO and is intended to provide funding for novel projects that have the potential to transform cancer care in resource-limited settings.</p><p>“We are thrilled to see Dr. Suwal receive this prestigious grant from ASCO,” said Dr. Binay Shah, President of the Binaytara Foundation. “Her research has the potential to make a significant impact on the lives of patients with oral cancer in Nepal and beyond. We are proud to support her work and look forward to the results of this important study.”</p><p>“Dr. Suwal’s research is key to improving the outcomes of oral cancer patients in Nepal and we are looking forward to seeing the results of this study. This screening model could be applied to other resource-poor areas and have an impact on communities around the world.” Added Dr. Siddhartha Yadav, Co-Chair of the Binaytara Foundation Education Academy.</p><p><strong>About the Binaytara Foundation</strong></p><p>The <a href="https://binayfoundation.org/">Binaytara Foundation</a> is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a <a href="https://cancer.binayfoundation.org/">cancer hospital in Nepal</a>.</p><p><strong>About the Binaytara Foundation Cancer Center</strong></p><p>The Binaytara Foundation Cancer Center is a cancer hospital in Janakpurdham, a city in southeast Nepal. It was established by the Binaytara Foundation in 2018 to meet the cancer care needs of more than six million residents of Madhesh Province (then province 2) who were forced to travel more than 8-hours by bus for cancer care at the nearest cancer hospital. The BTFCC provides cancer prevention, diagnosis, treatment, and palliative care services.</p><p><strong>About ASCO</strong></p><p>Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4daef41dc4b7" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[May brings skin cancer awareness just in time for summer]]></title>
            <link>https://btfnews.medium.com/may-brings-skin-cancer-awareness-just-in-time-for-summer-f3b1bce705a2?source=rss-a062686399a1------2</link>
            <guid isPermaLink="false">https://medium.com/p/f3b1bce705a2</guid>
            <dc:creator><![CDATA[Binaytara Foundation]]></dc:creator>
            <pubDate>Fri, 28 May 2021 21:02:18 GMT</pubDate>
            <atom:updated>2021-05-28T21:02:18.017Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*eQW2nfMhYLoRMsgf.png" /></figure><p>Skin cancer is the most <a href="https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/">common</a> type of cancer, with 5.4 million cases of nonmelanoma skin cancers in the US annually. Most of these, 8 out of 10, occur in basal cells, and a smaller fraction is found in squamous cells; both types of cells are found in the epidermis, the top layer of skin. Melanoma, skin cancer in the pigment-producing cells, impacts more than 200,000 people yearly. However, such cancers have very high recovery rates because their treatments harness the body’s immune system.</p><p>“For most patients, immunotherapy is a powerful tool, and we have clear evidence of good results,” <a href="https://www.seattlecca.org/providers/evan-t-hall">Dr. Evan Hall</a>, assistant professor of medicine at the University of Washington and medical-oncologist at Seattle Cancer Care Alliance, shares. “In some people, it clearly can work for years and years. We now have patients, eight or nine years after treatment for widespread metastatic melanoma throughout their body, that we can’t find any trace of cancer.”</p><p>Many patients find their cancer themselves when they notice hyperpigmented, asymmetrical skin lesions. Occasionally, dermatologists or primary care providers will spot them. The next step is getting the mole biopsied to identify if it’s cancerous or benign. If it is cancerous, patients return to their surgeons for a more extensive procedure.</p><p>“Even if the melanoma is completely excised, there’s a chance that it can come back within a radius around where it usually is,” Dr. Hall explains. “Surgeons take a couple of centimeter margin all the way around the tumor to remove additional tissue and reduce the chance of a recurrence near the original skin tumor.”</p><p>Skin cancer can metastasize to lymph nodes, lungs, liver, bones, and brain. If surgery is insufficient to remove cancer, medical oncologists are brought on board to administer therapies, particularly <a href="https://www.cancer.org/cancer/melanoma-skin-cancer/treating/immunotherapy.html">immunotherapy</a>, which are drugs that activate the immune system. Oncologists can use aggressive drug combinations for patients with metastatic disease or milder choices for those seeking adjunct therapy.</p><p>“We pick the right size hammer for the nail, so we are trying to use the appropriate strength immunotherapy, “Dr. Hall said. “As we use more and more immunotherapies together, the side effect rate goes up significantly.”</p><p>An overactive immune system could non-specifically attack functioning parts of the body, irritating normal tissues and causing side effects that can be life-threatening. This is especially a challenge for patients with immunosuppressed systems due to autoimmune diseases such as HIV/AIDS or organ transplants. For such patients, Dr. Hall tries to get “as much mileage out with a safer drug.” Chemotherapies have not shown to be as effective as immunotherapies and are much more toxic, especially in the long run, but <a href="https://www.cancer.org/cancer/melanoma-skin-cancer/treating/targeted-therapy.html">targeted therapies</a> are a promising avenue.</p><p>“One area that’s quite interesting is the idea of injecting immune-boosting medicines right into the tumors themselves,” Dr. Hall shares.</p><p>An easy way of keeping your <a href="https://www.skincancer.org/skin-cancer-prevention/">skin safe</a> is by using sunscreen with at least 30 <em>every day </em>(yes, even when there is no sun) to block UV rays. Staying away from tanning beds is also a great way to keep your skin healthy. There are also great <a href="https://blog.dana-farber.org/insight/2020/05/how-to-detect-skin-cancer-even-during-covid-19/">graphics</a> that show what you should be looking for on your skin to find any signs of skin cancer early.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f3b1bce705a2" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>